Shares of Pfizer Inc. (NYSE:PFE) jumped 1.34% to reach at $31.73 during previous trading session. The company has experienced volume of 37,422,335 shares while on average the company has a capacity of trading 28.35M share.
Pfizer Inc. (NYSE:PFE) Pfizer Inc. (PFE) on January 31, 2017 reported financial results for fourth-quarter and full-year 2016.
Pfizer manages its commercial operations through two distinct businesses: Pfizer Innovative Health (IH) (formerly the Innovative Products business) and Pfizer Essential Health (EH) (formerly the Established Products business).
On September 3, 2015, Pfizer acquired Hospira, Inc. (Hospira). Consequently, financial results for the year ended December 31, 2016 reflect legacy Hospira global operations for the entire period while financial results for the year ended December 31, 2015 reflect only four months of legacy Hospira U.S. operations and three months of legacy Hospira international operations. Financial results for fourth-quarter 2016 and fourth-quarter 2015 include legacy Hospira global operations for both periods.
On June 24, 2016, Pfizer acquired Anacor Pharmaceuticals, Inc. (Anacor). Therefore, financial results for fourth-quarter and full-year 2016 reflect three months and approximately six months of legacy Anacor operations, respectively, which were immaterial.
On September 28, 2016, Pfizer acquired Medivation, Inc. (Medivation). Therefore, financial results for fourth-quarter and full-year 2016 reflect three months of legacy Medivation operations.
Pfizer Inc. (NYSE:PFE) holds the market capitalization of $195.13B along with 6.07B outstanding shares. During the last trade, stock’s minimum price has been reached out at $30.93 while the maximum trading price moved at $31.93. Currently the stock price is moving -13.58% off from the highest level of twelve months and +15.41% above from twelve months low. Pfizer Inc. (NYSE:PFE) marked 52-week highest price level of $36.72 on 08/01/16 and 52-week lowest price level of $27.49 on 02/08/16. For the stock, price target value has been calculated at $37.48 based on calls of 21 experts. Stock’s minimum price target estimates has been figured out at $30.00 while the maximum price target forecast is established at $52.00.
As of current trade, Pfizer Inc. (NYSE:PFE) has shown weekly upbeat performance of 1.86%. Its six months performance indicated a bearish movement while its yearly performance reflected a positive trend of 9.15%. Year-to-date (YTD) performance of the stock illustrate downbeat trend of -2.31%. Shares of Pfizer Inc. (NYSE:PFE) currently have an ABR of 2.06, derived from a total of 17 opinions. The company’s price sits -1.27% below from its 50-day moving average of $32.41 and -4.64% below from the stock’s 200-day moving average of $33.33. The company has Relative Strength Index (RSI 14) of 44.51 along with Average True Range (ATR 14) of 0.47. Its weekly and monthly volatility is 1.55%, 1.46% respectively. The company’s beta value is at 0.92.
Pfizer Inc. (NYSE:PFE) currently has a PEG ratio of 4.48 where as its P/E ratio is 31.67. The company’s price to sales ratio for trailing twelve months is 3.62 and price to book ratio for most recent quarter is 3.04, whereas price to cash per share for the most recent quarter is 13.40. Pfizer Inc. (NYSE:PFE)’s price to free cash flow for trailing twelve months is 108.11. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48. Pfizer Inc. (NYSE:PFE) has a Return on Assets of 3.60%. The company currently has a Return on Equity of 9.70% and Return on Investment of 7.30%.